Céline Berthon

6.0k citations
77 papers · 2.1k · 1 hit paper · h-index 22

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
  • Genetics top 2%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

  • Hematology 56
    • Acute Myeloid Leukemia Research 39
    • Multiple Myeloma Research and Treatments 14
    • Chronic Myeloid Leukemia Treatments 10
    • Hematopoietic Stem Cell Transplantation 7
  • Molecular Biology 22
    • Protein Degradation and Inhibitors 8
Co-authors
Bruno Quesnel (27 shared papers)Claude Preudhomme (32 shared papers)Emmanuel Raffoux (9 shared papers)Nathalie Jouy (6 shared papers)Dominique Hétuin (3 shared papers)Christophe Roumier (12 shared papers)Christian Récher (8 shared papers)Xavier Leleu (7 shared papers)
Journals
Blood (25 papers)Leukemia Research (8 papers)Blood Advances (3 papers)Cancers (3 papers)British Journal of Haematology (2 papers)
Partner nations
FranceUnited KingdomGermany

In The Last Decade

Céline Berthon

74 papers receiving 2.1k citations

Céline Berthon's Hit Papers

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study 2016 · 336 citations
3360+3+6Years since publication100200300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2016 The Lancet Haematology

Peers

Céline Berthon
Comparison fields: 5 of 93
  • Hematology 1.3k
  • Genetics 370
  • Biological Psychiatry 62
  • Oncology 496
  • Public Health, Environmental and Occupational Health 462
Replace Susan O’Brien with:
Susan O’Brien United States
Beatrice U. Mueller Switzerland
Merav Leiba Israel
Oleg I. Krijanovski United States
Peter Gimsing Denmark
Christine Hartford United States
Scott W. Baumgartner United States
Maximilian Stahl United States
Jan Philipp Bewersdorf United States
Céline Berthon relative to Susan O’Brien United States Susan O’Brien's profile →
Citations per field
00.5×2×3×4×4.8×
Susan O’Brien · 1×
Citations per year

Countries citing papers authored by Céline Berthon

Since Specialization
Citations

This map shows the geographic impact of Céline Berthon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Berthon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Berthon more than expected).

Fields of papers citing papers by Céline Berthon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Berthon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Berthon. The network helps show where Céline Berthon may publish in the future.

Co-authors

The 25 scholars most cited alongside Céline Berthon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Céline Berthon Line = papers co-authored together Céline Berthon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
The Lancet Haematology ·Céline Berthon, Emmanuel Raffoux, Xavier Thomas, Norbert Vey, Carlos Gomez‐Roca, Karen Yee, David Taussig, Keyvan Rezaï, Christophe Roumier, Patrice Herait, Carmen Kahatt, Bruno Quesnel, Mauricette Michallet, Christian Récher, François Lokiec, Claude Preudhomme, Hervé Dombret
Hit paper breakdown →		2016336
2
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia
Blood ·Yves Chalandon, Xavier Thomas, Sandrine Hayette, Jean‐Michel Cayuela, Claire Abbal, Françoise Huguet, Emmanuel Raffoux, Thibaut Leguay, Philippe Rousselot, Stéphane Leprêtre, Martine Escoffre‐Barbe, Sébastien Maury, Céline Berthon, Emmanuelle Tavernier, Jean‐François Lambert, Mårina Lafage‐Pochitaloff, Véronique Lhéritier, Sylvie Chevret, Norbert Ifrah, Hervé Dombret
2015239
3
Clonal architecture of chronic myelomonocytic leukemias
Blood ·Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Margot Morabito, Claude Preudhomme, Céline Berthon, Lionel Adès, Pierre Fenaux, Uwe Platzbecker, Olivier Gagey, Philippe Rameau, Guillaume Meurice, Cédric Oréar, François Delhommeau, Olivier Bernard, Michaëla Fontenay, William Vainchenker, Nathalie Droin, Éric Solary
2013184
4
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
Cancer Immunology Immunotherapy ·Céline Berthon, Virginie Driss, Jizhong Liu, Klaudia Kuranda, Xavier Leleu, Nathalie Jouy, Dominique Hétuin, Bruno Quesnel
2010133
5
RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage
Cell Death and Disease ·A-L Nugues, Hassiba El Bouazzati, Dominique Hétuin, Céline Berthon, Anne Loyens, Elisabeth Bertrand, Nathalie Jouy, Thierry Idziorek, Bruno Quesnel
2014107
6
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
Leukemia ·Aline Renneville, Nicolas Boissel, Olivier Nibourel, Céline Berthon, Nathalie Hélevaut, Claude Gardin, JM Cayuela, Sandrine Hayette, Oumédaly Reman, Nathalie Contentin, Dominique Bordessoule, Cécile Pautas, Stéphane de Botton, Thierry de Revel, Christine Terré, Pierre Fenaux, X. Thomas, Sylvie Castaigné, Hervé Dombret, Claude Preudhomme
201289
7
Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients’ sera by HPLC and is inducible by IFN-γ
Leukemia Research ·Sélim Corm, Céline Berthon, M. Imbenotte, Valéria Biggio, Michel Lhermitte, Caroline Dupont, Isabelle Briche, Bruno Quesnel
200884
8
Enteral Feeding and Early Outcomes of Patients Undergoing Allogeneic Stem Cell Transplantation Following Myeloablative Conditioning
Transplantation ·D. Séguy, Céline Berthon, Jean‐Baptiste Micol, Stéphane Darre, Jean‐Hugues Dalle, Sylvain Neuville, F Bauters, Jean‐Pierre Jouet, Ibrahim Yakoub‐Agha
200676
9
Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup
Blood ·Thomas Prébet, Sarah Bertoli, Xavier Thomas, Emmanuelle Tavernier, Thorsten Braun, Cécile Pautas, Aurore Perrot, Bruno Lioure, Philippe Rousselot, Jérôme Tamburini, Thomas Cluzeau, Johanna Konopacki, Edouard Randriamalala, Céline Berthon, Marie-Pierre Gourin, Christian Récher, Jean‐Yves Cahn, Norbert Ifrah, Hervé Dombret, Nicolas Boissel
201458
10
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia
Leukemia Research ·Emna Abdelhamid, Claude Preudhomme, Nathalie Hélevaut, Olivier Nibourel, Claude Gardin, Philippe Rousselot, Sylvie Castaigné, Bérengère Gruson, Céline Berthon, Zohra Soua, Aline Renneville
201144
11
Impact of Initial FDG-PET/CT and Serum-Free Light Chain on Transformation of Conventionally Defined Solitary Plasmacytoma to Multiple Myeloma
Clinical Cancer Research ·Guillemette Fouquet, Stéphanie Guidez, Charles Herbaux, Zoé Van de Wyngaert, Sarah Bonnet, David Beauvais, Hélène Demarquette, Salim M. Adib, Bénédicte Hivert, Mathieu Wémeau, Céline Berthon, Louis Terriou, Valérie Coiteux, Margaret Macro, Olivier Decaux, Thierry Façon, D. Huglo, Xavier Leleu
201442
12
GILZ inhibits the mTORC2/AKT pathway in BCR-ABL+ cells
Oncogene ·Sami Joha, A-L Nugues, Dominique Hétuin, Céline Berthon, Xavier Dezitter, Véronique Dauphin, F-X Mahon, Catherine Roche‐Lestienne, Claude Preudhomme, Bruno Quesnel, Thierry Idziorek
201140
13
Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
Leukemia & lymphoma ·Marie‐Anne Couturier, Xavier Thomas, Emmanuel Raffoux, Françoise Huguet, Céline Berthon, Célestine Simand, Maria-Pilar Gallego-Hernanz, Yosr Hicheri, Mathilde Hunault Berger, Colombe Saillard, Thibaut Leguay, Clémence Loiseau, Marie C. Béné, Patrice Chevallier
202040
14
Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure
Leukemia Research ·Stéphanie Harel, Amina Cherait, Céline Berthon, Christophe Willekens, Sophie Park, Marthe Rigal, Sabine Bréchignac, Sylvain Thépot, Bruno Quesnel, Claude Gardin, Lionel Adès, Pierre Fenaux, Thorsten Braun
201538
15
The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest
Haematologica ·Raouf Ben Abdelali, Vahid Asnafi, Arnaud Petit, Jean‐Baptiste Micol, Céline Callens, Patrick Villarèse, Éric Delabesse, Oumédaly Reman, Stéphane Leprêtre, Jean‐Yves Cahn, Gaëlle Guillerm, Céline Berthon, Claude Gardin, Bernadette Corront, Thibaut Leguay, Massimiliano Del Bene, Norbert Ifrah, G Leverger, Hervé Dombret, Elizabeth Macintyre
201335
16
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
Cancers ·Thomas Boyer, Fanny Gonzales, Adeline Barthélémy, Alice Marceau‐Renaut, Pauline Peyrouze, Soizic Guihard, Pascale Lepelley, Adriana Pleșa, Olivier Nibourel, Carole Delattre, Marc Wetterwald, Nicolas Pottier, Isabelle Plantier, Stéphane de Botton, Hervé Dombret, Céline Berthon, Claude Preudhomme, Christophe Roumier, Meyling Cheok
201929
17
A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Advanced Acute Leukemia
Blood ·Hervé Dombret, Claude Preudhomme, Céline Berthon, Emmanuel Raffoux, Xavier Thomas, Norbert Vey, Carlos Gomez‐Roca, Mark Ethell, Karen Yee, Fabrice Bourdel, Patrice Herait, Mauricette Michallet, Christian Récher, Christophe Roumier, Bruno Quesnel
201429
18
A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients
Experimental Hematology ·Klaudia Kuranda, Céline Berthon, Caroline Dupont, Dariusz Wołowiec, Xavier Leleu, Renata Polakowska, Nathalie Jouy, Bruno Quesnel
200926
19
Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification
Leukemia Research ·Céline Berthon, Michaëla Fontenay, Sélim Corm, Isabelle Briche, Delphine Allorge, Benjamin Hennart, Michel Lhermitte, Bruno Quesnel
201326
20
Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70‐year old: A phase 1/2 study of the acute leukemia French association
American Journal of Hematology ·H. Farhat, Oumédaly Reman, Emmanuel Raffoux, Céline Berthon, Cécile Pautas, L. Kammoun, Sylvain Chantepie, Claude Gardin, Philippe Rousselot, Sylvie Chevret, Hervé Dombret, Sylvie Castaigné
201126

About Céline Berthon

Céline Berthon is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Public Health, Environmental and Occupational Health, having authored 77 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (39 papers), Acute Lymphoblastic Leukemia research (15 papers), Multiple Myeloma Research and Treatments (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Chronic Myeloid Leukemia Treatments (10 papers), Protein Degradation and Inhibitors (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (370 citations), Biological Psychiatry (62 citations), Oncology (496 citations) and Public Health, Environmental and Occupational Health (462 citations). Céline Berthon has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include Bruno Quesnel, Claude Preudhomme, Emmanuel Raffoux, Nathalie Jouy, Dominique Hétuin, Christophe Roumier, Christian Récher, Xavier Leleu, Norbert Vey and Aline Renneville. Their work appears in journals such as Blood, Leukemia Research, Blood Advances, Cancers and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan O’BrienBreakdown of academic impact, for papers by Beatrice U. MuellerBreakdown of academic impact, for papers by Merav LeibaBreakdown of academic impact, for papers by Oleg I. KrijanovskiBreakdown of academic impact, for papers by Peter GimsingBreakdown of academic impact, for papers by Christine HartfordBreakdown of academic impact, for papers by Scott W. BaumgartnerBreakdown of academic impact, for papers by Maximilian StahlBreakdown of academic impact, for papers by Jan Philipp Bewersdorf